Ensuring effective prevention of iodine deficiency disorders

Henry Völzke, Philippe Caron, Lisbeth Dahl, João J. De Castro, Iris Erlund, Simona Gaberšček, Ingibjörg Gunnarsdottir, Alicja Hubalewska-Dydejczyk, Till Ittermann, Ludmila Ivanova, Borislav Karanfilski, Rehman M. Khattak, Zvonko Kusić, Peter Laurberg, John H. Lazarus, Kostas B. Markou, Rodrigo Moreno-Reyes, E. Nagy, Robin P. Peeters, Valdis PiragsJán Podoba, Margaret P. Rayman, Ursula Rochau, Uwe Siebert, Peter P. Smyth, Betina H. Thuesen, Aron Troen, Lluís Vila, Paolo Vitti, Vaclav Zamrazil, Michael B. Zimmermann

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: Programs initiated to prevent iodine deficiency disorders (IDD) may not remain effective due to changes in government policies, commercial factors, and human behavior that may affect the efficacy of IDD prevention programs in unpredictable directions. Monitoring and outcome studies are needed to optimize the effectiveness of IDD prevention. Summary: Although the need for monitoring is compelling, the current reality in Europe is less than optimal. Regular and systematic monitoring surveys have only been established in a few countries, and comparability across the studies is hampered by the lack of centralized standardization procedures. In addition, data on outcomes and the cost of achieving them are needed in order to provide evidence of the beneficial effects of IDD prevention in countries with mild iodine deficiency. Conclusion: Monitoring studies can be optimized by including centralized standardization procedures that improve the comparison between studies. No study of iodine consumption can replace the direct measurement of health outcomes and the evaluation of the costs and benefits of the program. It is particularly important that health economic evaluation should be conducted in mildly iodine-deficient areas and that it should include populations from regions with different environmental, ethnic, and cultural backgrounds.

Original languageEnglish
Pages (from-to)189-196
Number of pages8
JournalThyroid
Volume26
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

Iodine
Cost-Benefit Analysis
Health
Outcome Assessment (Health Care)
Costs and Cost Analysis
Population

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Völzke, H., Caron, P., Dahl, L., De Castro, J. J., Erlund, I., Gaberšček, S., ... Zimmermann, M. B. (2016). Ensuring effective prevention of iodine deficiency disorders. Thyroid, 26(2), 189-196. https://doi.org/10.1089/thy.2015.0543

Ensuring effective prevention of iodine deficiency disorders. / Völzke, Henry; Caron, Philippe; Dahl, Lisbeth; De Castro, João J.; Erlund, Iris; Gaberšček, Simona; Gunnarsdottir, Ingibjörg; Hubalewska-Dydejczyk, Alicja; Ittermann, Till; Ivanova, Ludmila; Karanfilski, Borislav; Khattak, Rehman M.; Kusić, Zvonko; Laurberg, Peter; Lazarus, John H.; Markou, Kostas B.; Moreno-Reyes, Rodrigo; Nagy, E.; Peeters, Robin P.; Pirags, Valdis; Podoba, Ján; Rayman, Margaret P.; Rochau, Ursula; Siebert, Uwe; Smyth, Peter P.; Thuesen, Betina H.; Troen, Aron; Vila, Lluís; Vitti, Paolo; Zamrazil, Vaclav; Zimmermann, Michael B.

In: Thyroid, Vol. 26, No. 2, 01.02.2016, p. 189-196.

Research output: Contribution to journalArticle

Völzke, H, Caron, P, Dahl, L, De Castro, JJ, Erlund, I, Gaberšček, S, Gunnarsdottir, I, Hubalewska-Dydejczyk, A, Ittermann, T, Ivanova, L, Karanfilski, B, Khattak, RM, Kusić, Z, Laurberg, P, Lazarus, JH, Markou, KB, Moreno-Reyes, R, Nagy, E, Peeters, RP, Pirags, V, Podoba, J, Rayman, MP, Rochau, U, Siebert, U, Smyth, PP, Thuesen, BH, Troen, A, Vila, L, Vitti, P, Zamrazil, V & Zimmermann, MB 2016, 'Ensuring effective prevention of iodine deficiency disorders', Thyroid, vol. 26, no. 2, pp. 189-196. https://doi.org/10.1089/thy.2015.0543
Völzke H, Caron P, Dahl L, De Castro JJ, Erlund I, Gaberšček S et al. Ensuring effective prevention of iodine deficiency disorders. Thyroid. 2016 Feb 1;26(2):189-196. https://doi.org/10.1089/thy.2015.0543
Völzke, Henry ; Caron, Philippe ; Dahl, Lisbeth ; De Castro, João J. ; Erlund, Iris ; Gaberšček, Simona ; Gunnarsdottir, Ingibjörg ; Hubalewska-Dydejczyk, Alicja ; Ittermann, Till ; Ivanova, Ludmila ; Karanfilski, Borislav ; Khattak, Rehman M. ; Kusić, Zvonko ; Laurberg, Peter ; Lazarus, John H. ; Markou, Kostas B. ; Moreno-Reyes, Rodrigo ; Nagy, E. ; Peeters, Robin P. ; Pirags, Valdis ; Podoba, Ján ; Rayman, Margaret P. ; Rochau, Ursula ; Siebert, Uwe ; Smyth, Peter P. ; Thuesen, Betina H. ; Troen, Aron ; Vila, Lluís ; Vitti, Paolo ; Zamrazil, Vaclav ; Zimmermann, Michael B. / Ensuring effective prevention of iodine deficiency disorders. In: Thyroid. 2016 ; Vol. 26, No. 2. pp. 189-196.
@article{71a6c0cdfb754063aead9f1b75ca4abd,
title = "Ensuring effective prevention of iodine deficiency disorders",
abstract = "Background: Programs initiated to prevent iodine deficiency disorders (IDD) may not remain effective due to changes in government policies, commercial factors, and human behavior that may affect the efficacy of IDD prevention programs in unpredictable directions. Monitoring and outcome studies are needed to optimize the effectiveness of IDD prevention. Summary: Although the need for monitoring is compelling, the current reality in Europe is less than optimal. Regular and systematic monitoring surveys have only been established in a few countries, and comparability across the studies is hampered by the lack of centralized standardization procedures. In addition, data on outcomes and the cost of achieving them are needed in order to provide evidence of the beneficial effects of IDD prevention in countries with mild iodine deficiency. Conclusion: Monitoring studies can be optimized by including centralized standardization procedures that improve the comparison between studies. No study of iodine consumption can replace the direct measurement of health outcomes and the evaluation of the costs and benefits of the program. It is particularly important that health economic evaluation should be conducted in mildly iodine-deficient areas and that it should include populations from regions with different environmental, ethnic, and cultural backgrounds.",
author = "Henry V{\"o}lzke and Philippe Caron and Lisbeth Dahl and {De Castro}, {Jo{\~a}o J.} and Iris Erlund and Simona Gaberšček and Ingibj{\"o}rg Gunnarsdottir and Alicja Hubalewska-Dydejczyk and Till Ittermann and Ludmila Ivanova and Borislav Karanfilski and Khattak, {Rehman M.} and Zvonko Kusić and Peter Laurberg and Lazarus, {John H.} and Markou, {Kostas B.} and Rodrigo Moreno-Reyes and E. Nagy and Peeters, {Robin P.} and Valdis Pirags and J{\'a}n Podoba and Rayman, {Margaret P.} and Ursula Rochau and Uwe Siebert and Smyth, {Peter P.} and Thuesen, {Betina H.} and Aron Troen and Llu{\'i}s Vila and Paolo Vitti and Vaclav Zamrazil and Zimmermann, {Michael B.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1089/thy.2015.0543",
language = "English",
volume = "26",
pages = "189--196",
journal = "Thyroid",
issn = "1050-7256",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Ensuring effective prevention of iodine deficiency disorders

AU - Völzke, Henry

AU - Caron, Philippe

AU - Dahl, Lisbeth

AU - De Castro, João J.

AU - Erlund, Iris

AU - Gaberšček, Simona

AU - Gunnarsdottir, Ingibjörg

AU - Hubalewska-Dydejczyk, Alicja

AU - Ittermann, Till

AU - Ivanova, Ludmila

AU - Karanfilski, Borislav

AU - Khattak, Rehman M.

AU - Kusić, Zvonko

AU - Laurberg, Peter

AU - Lazarus, John H.

AU - Markou, Kostas B.

AU - Moreno-Reyes, Rodrigo

AU - Nagy, E.

AU - Peeters, Robin P.

AU - Pirags, Valdis

AU - Podoba, Ján

AU - Rayman, Margaret P.

AU - Rochau, Ursula

AU - Siebert, Uwe

AU - Smyth, Peter P.

AU - Thuesen, Betina H.

AU - Troen, Aron

AU - Vila, Lluís

AU - Vitti, Paolo

AU - Zamrazil, Vaclav

AU - Zimmermann, Michael B.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Background: Programs initiated to prevent iodine deficiency disorders (IDD) may not remain effective due to changes in government policies, commercial factors, and human behavior that may affect the efficacy of IDD prevention programs in unpredictable directions. Monitoring and outcome studies are needed to optimize the effectiveness of IDD prevention. Summary: Although the need for monitoring is compelling, the current reality in Europe is less than optimal. Regular and systematic monitoring surveys have only been established in a few countries, and comparability across the studies is hampered by the lack of centralized standardization procedures. In addition, data on outcomes and the cost of achieving them are needed in order to provide evidence of the beneficial effects of IDD prevention in countries with mild iodine deficiency. Conclusion: Monitoring studies can be optimized by including centralized standardization procedures that improve the comparison between studies. No study of iodine consumption can replace the direct measurement of health outcomes and the evaluation of the costs and benefits of the program. It is particularly important that health economic evaluation should be conducted in mildly iodine-deficient areas and that it should include populations from regions with different environmental, ethnic, and cultural backgrounds.

AB - Background: Programs initiated to prevent iodine deficiency disorders (IDD) may not remain effective due to changes in government policies, commercial factors, and human behavior that may affect the efficacy of IDD prevention programs in unpredictable directions. Monitoring and outcome studies are needed to optimize the effectiveness of IDD prevention. Summary: Although the need for monitoring is compelling, the current reality in Europe is less than optimal. Regular and systematic monitoring surveys have only been established in a few countries, and comparability across the studies is hampered by the lack of centralized standardization procedures. In addition, data on outcomes and the cost of achieving them are needed in order to provide evidence of the beneficial effects of IDD prevention in countries with mild iodine deficiency. Conclusion: Monitoring studies can be optimized by including centralized standardization procedures that improve the comparison between studies. No study of iodine consumption can replace the direct measurement of health outcomes and the evaluation of the costs and benefits of the program. It is particularly important that health economic evaluation should be conducted in mildly iodine-deficient areas and that it should include populations from regions with different environmental, ethnic, and cultural backgrounds.

UR - http://www.scopus.com/inward/record.url?scp=84958047952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958047952&partnerID=8YFLogxK

U2 - 10.1089/thy.2015.0543

DO - 10.1089/thy.2015.0543

M3 - Article

C2 - 26700864

AN - SCOPUS:84958047952

VL - 26

SP - 189

EP - 196

JO - Thyroid

JF - Thyroid

SN - 1050-7256

IS - 2

ER -